Wolters Kluwer Health has been recognized as one of the top performers in the Clinical Decision Support Systems (CDSS) sector, according to the 2025 Frost Radar™ report by Frost & Sullivan. The analysis, which evaluated more than 60 CDSS providers, identified Wolters Kluwer among the top two companies, highlighting its sustained leadership in the field.
The Frost Radar assessment emphasized Wolters Kluwer’s strong market position, citing the company’s significant investment in research and development and the strategic incorporation of emerging technologies such as generative artificial intelligence. These initiatives have contributed to the company's advancement of next-generation CDSS solutions.
Wolters Kluwer was also recognized for its recent product developments, notably the introduction of UpToDate Enterprise Edition. This platform aims to enhance collaboration among buyers, administrators, and care teams by consolidating information into a unified system. The platform offers advanced analytics to provide insights on product utilization, community engagement, education requirements, and overall impact on healthcare systems.
The company’s continued growth in the CDSS market has been attributed to its focus on product innovation, integration of clinical decision support into clinician workflows, and the extension of its solutions to address operational and financial processes in healthcare settings. Wolters Kluwer Health’s recent integrations with ambient AI technology providers, including Abridge, Suki, and Microsoft, further support its efforts to improve clinical workflows and decision-making capabilities.
According to Frost & Sullivan, Wolters Kluwer’s consistent focus on innovation, combined with its efforts to expand the reach and impact of its solutions, has positioned it as a market leader in the CDSS sector.
Click here to read the original press release.
